Study on TP53 Codon 72 Polymorphisms with Oral Carcinoma Susceptibility

Archives of Medical Research

Volumn 40, Issue 7, 2009, Pages 625-634

  Zhuo, Xian Lu ^a,b   Li, Qi ^a   Zhou, Yan ^a   Cai, Lei ^a   Xiang, Zhao Lan ^a   Yuan, Wei ^a   Zhang, Xue Yuan ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b GUIZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Meta analysis; Oral carcinoma; Polymorphism; Susceptibility; TP53 codon 72

Indexed keywords

ARGININE; PROLINE; PROTEIN P53;

ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CODON; DATA BASE; EVIDENCE BASED PRACTICE; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MOUTH CARCINOMA; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; SENSITIVITY ANALYSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CODON; DATABASES, FACTUAL; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 71649091527     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.arcmed.2009.09.004     Document Type: Article

References (51)

1. Zhuo W., Wang Y., Zhuo X., et al. CYP1A1 and GSTM1 polymorphisms and oral cancer risk: association studies via evidence-based meta-analyses. Cancer Invest 27 (2009) 86-95
2. Yapijakis C., Kechagiadakis M., Nkenke E., et al. Association of leptin -2548G/A and leptin receptor Q223R polymorphisms with increased risk for oral cancer. J Cancer Res Clin Oncol (2008) doi: 10.1007/s00432-008-0494-z
3. Vairaktaris E., Serefoglou Z., Avgoustidis D., et al. Gene polymorphisms related to angiogenesis, inflammation and thrombosis that influence risk for oral cancer. Oral Oncol (2008) doi:10.1016/j.oraloncology.2008.05.003
4. Tseng H.C., Tsai M.H., Chiu C.F., et al. Association of XRCC4 codon 247 polymorphism with oral cancer susceptibility in Taiwan. Anticancer Res 28 (2008) 1687-1691
5. Cheng C.Y., Chang C.S., Liu C.J., et al. Vascular endothelial growth factor 936 C/T polymorphism is associated with vascular invasion in oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106 (2008) 79-84
6. Bumroongkit K., Rannala B., Traisathit P., et al. TP53 gene mutations of lung cancer patients in upper northern Thailand and environmental risk factors. Cancer Genet Cytogenet 185 (2008) 20-27
7. Assumpcao J.G., Seidinger A.L., Mastellaro M.J., et al. Association of the germline TP53 R337H mutation with breast cancer in southern Brazil. BMC Cancer 8 (2008) 357
8. Mahdavinia M., Bishehsari F., Verginelli F., et al. P53 mutations in colorectal cancer from northern Iran: relationships with site of tumor origin, microsatellite instability and K-ras mutations. J Cell Physiol 216 (2008) 543-550
9. Hassan N.M., Tada M., Hamada J., et al. Presence of dominant negative mutation of TP53 is a risk of early recurrence in oral cancer. Cancer Lett 270 (2008) 108-119
10. Kuo M.Y., Huang J.S., Hsu H.C., et al. Infrequent p53 mutations in patients with areca quid chewing-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 28 (1999) 221-225
11. Acha-Sagredo A, Ruesga MT, Rodriguez C, et al. p53 mutation is rare in oral mucosa brushings from patients previously treated for a head and neck squamous cell carcinoma. Oral Oncol doi:doi:10.1016/j.oraloncology. 2008.10.002
12. Ara S., Lee P.S., Hansen M.F., et al. Codon 72 polymorphism of the TP53 gene. Nucleic Acids Res 18 (1990) 4961
13. Shen H., Solari A., Wang X., et al. P53 codon 72 polymorphism and risk of gastric cancer in a Chinese population. Oncol Rep 11 (2004) 1115-1120
14. Bonafé M., Ceccarelli C., Farabegoli F., et al. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients. Clin Cancer Res 9 (2003) 4860-4864
15. Storey A., Thomas M., Kalita A., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234
16. Wang Y.C., Lee H.S., Chen S.K., et al. Prognostic significance of p53 codon 72 polymorphism in lung carcinomas. Eur J Cancer 35 (1999) 226-230
17. Yu M.W., Yang S.Y., Chiu Y.H., et al. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology 29 (1999) 697-702
18. Mabrouk I., Baccouche S., El-Abed R., et al. No evidence of correlation between p53 codon 72 polymorphism and risk of bladder or breast carcinoma in Tunisian patients. Ann N Y Acad Sci 1010 (2003) 764-770
19. Munafò M.R., Clark T.G., and Flint J. Assessing publication bias in genetic association studies: evidence from a recent meta-analysis. Psychiatry Res 129 (2004) 39-44
20. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 315 (1997) 629-634
21. Ji X., Neumann A.S., Sturgis E.M., et al. p53 codon 72 polymorphism associated with risk of human papillomavirus-associated squamous cell carcinoma of the oropharynx in never-smokers. Carcinogenesis 29 (2008) 875-879
22. Cortezzi S.S., Provazzi P.J., Sobrinho J.S., et al. Analysis of human papillomavirus prevalence and TP53 polymorphism in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 150 (2004) 44-49
23. Schneider-Stock R., Mawrin C., Motsch C., et al. Retention of the arginine allele in codon 72 of the p53 gene correlates with poor apoptosis in head and neck cancer. Am J Pathol 164 (2004) 1233-1241
24. Tandle A.T., Sanghvi V., and Saranath D. Determination of p53 genotypes in oral cancer patients from India. Br J Cancer 84 (2001) 739-742
25. Drummond S.N., De Marco L., Pordeus Ide A., et al. TP53 codon 72 polymorphism in oral squamous cell carcinoma. Anticancer Res 22 (2002) 3379-3381
26. Kietthubthew S., Sriplung H., Au W.W., et al. The p53 codon 72 polymorphism and risk of oral cancer in Southern Thailand. Asian Pac J Cancer Prev 4 (2003) 209-214
27. Bau D.T., Tsai M.H., Lo Y.L., et al. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients. Anticancer Res 27 (2007) 1559-1564
28. Summersgill K.F., Smith E.M., Kirchner H.L., et al. p53 polymorphism, human papillomavirus infection in the oral cavity, and oral cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 90 (2000) 334-339
29. Shen H., Zheng Y., Sturgis E.M., et al. P53 codon 72 polymorphism and risk of squamous cell carcinoma of the head and neck: a case-control study. Cancer Lett 183 (2002) 123-130
30. Nagpal J.K., Patnaik S., and Das B.R. Prevalence of high-risk human papilloma virus types and its association with P53 codon 72 polymorphism in tobacco addicted oral squamous cell carcinoma (OSCC) patients of Eastern India. Int J Cancer 97 (2002) 649-653
31. Katiyar S., Thelma B.K., Murthy N.S., et al. Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India. Mol Cell Biochem 252 (2003) 117-124
32. Hsieh L.L., Huang T.H., Chen I.H., et al. p53 polymorphisms associated with mutations in and loss of heterozygosity of the p53 gene in male oral squamous cell carcinomas in Taiwan. Br J Cancer 92 (2005) 30-35
33. Kuroda Y., Nakao H., Ikemura K., et al. Association between the TP53 codon72 polymorphism and oral cancer risk and prognosis. Oral Oncol 43 (2007) 1043-1048
34. Tu H.F., Chen H.W., Kao S.Y., et al. MDM2 SNP 309 and p53 codon 72 polymorphisms are associated with the outcome of oral carcinoma patients receiving postoperative irradiation. Radiother Oncol 87 (2008) 243-252
35. Chen X., Sturgis E.M., El-Naggar A.K., et al. Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokers. Carcinogenesis 29 (2008) 2120-2125
36. Lin Y.C., Huang H.I., Wang L.H., et al. Polymorphisms of COX-2 -765G > C and p53 codon 72 and risks of oral squamous cell carcinoma in a Taiwan population. Oral Oncol 44 (2008) 798-804
37. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 327 (2003) 557-560
38. Tobias A. Assessing the influence of a single study in the meta-analysis estimate. Stata Techn Bull 8 (1999) 15-17
39. Koushik A., Platt R.W., and Franco E.L. p53 codon 72 polymorphism and cervical neoplasia: a meta-analysis review. Cancer Epidemiol Biomarkers Prev 13 (2004) 11-22
40. Jee S.H., Won S.Y., Yun J.E., et al. Polymorphism p53 codon-72 and invasive cervical cancer: a meta-analysis. Int J Gynaecol Obstet 85 (2004) 301-308
41. Sousa H., Santos A.M., Pinto D., et al. Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European populations. Int J Mol Med 20 (2007) 731-741
42. Zhuo X.L., Cai L., Xiang Z.L., et al. TP53 codon 72 polymorphisms contributes to nasopharyngeal cancer susceptibility: a meta-analysis. Arch Med Res 40 (2009) 299-305
43. Matakidou A., Eisen T., and Houlston R.S. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 18 (2003) 377-385
44. Zhou Y., Li N., Zhuang W., et al. P53 codon 72 polymorphism and gastric cancer: a meta-analysis of the literature. Int J Cancer 121 (2007) 1481-1486
45. Li Y., Qiu L.X., Shen X.K., et al. A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15,857 subjects. Lung Cancer (2009) doi:10.1016/j.lungcan.2008.12.009
46. Pietsch E.C., Humbey O., and Murphy M.E. Polymorphisms in the p53 pathway. Oncogene 25 (2006) 1602-1611
47. Dumont P., Leu J.I., Della Pietra III A.C., et al. The codon 72 polymorphic variants of p53 have markedly different apoptotic potential. Nat Genet 33 (2003) 357-365
48. Chang C.C., Hsieh Y.Y., Tsai F.J., et al. The proline form of p53 codon 72 polymorphism is associated with endometriosis. Fertil Steril 77 (2002) 43-45
49. Ye Y., Lippman S.M., Lee J.J., et al. Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions. Cancer 113 (2008) 2488-2495
50. Miller C.S., and Johnstone B.M. Human papillomavirus as a risk factor for oral squamous cell carcinoma: a meta-analysis, 1982-1997. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 91 (2001) 622-635
51. Storey A., Thomas M., Kalita A., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 393 (1998) 229-234